Aichi, Japan

Yukari Matsumoto

This inventor holds 4 USPTO granted patents. Top assignees: Pfizer Corporation, Raqualia Pharma Inc., Requalia Pharma Inc.. Active years: 2007-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukari Matsumoto. Retrieved from https://idiyas.com/inventor/yukari-matsumoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Chita-gun, JP (2009)
  • Aichi-Ken, JP (2007 - 2011)

Company Filing History:


Years Active: 2007-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yukari Matsumoto: Innovator in Pharmaceutical Chemistry

Introduction

Yukari Matsumoto is a prominent inventor based in Aichi-ken, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 4 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

One of her latest patents includes the invention of substituted methyl aryl or heteroaryl amide compounds. This invention provides a compound of the formula (I), which has potential applications in various therapeutic areas. The innovative nature of her work reflects her commitment to advancing pharmaceutical research.

Career Highlights

Throughout her career, Yukari has worked with notable companies such as Pfizer Corporation and Requalia Pharma Inc. Her experience in these organizations has allowed her to develop her expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Yukari has collaborated with esteemed colleagues, including Hiroki Koike and Kazunari Nakao. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Yukari Matsumoto is a trailblazer in pharmaceutical chemistry, with a focus on developing innovative compounds. Her contributions and collaborations continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…